Congenital toxoplasmosis: the importance of the western blot method to avoid unnecessary therapy in potentially infected newborns.
Tridapalli
E
E
Department of Preventive Paediatrics and Neonatology, St. Orsola-Malpighi General Hospital, University of Bologna, Bologna, Italy. elisabetta.tridapalli@aosp.bo.it
Capretti
Mg
M
Farneti
G
G
Marangoni
A
A
Cevenini
R
R
Faldella
G
G
D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood*; D000953:Antigens, Protozoan / Q000097:blood*; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000009:adverse effects; D015153:Blotting, Western / Q000379:methods*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000097:blood; D014122:Toxoplasma / Q000276:immunology / Q000472:pathogenicity; D014125:Toxoplasmosis, Congenital / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000635:transmission
D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D000981:Antiprotozoal Agents; D007074:Immunoglobulin G; D007075:Immunoglobulin M